Naushad Hirani - Concepedia

Author

Naushad Hirani

University of Calgary ORCID

Also Known As

N. A. Hirani, N. Hirani, NAUSHAD HIRANI, Naushad Hirani

Publications

828

Citations

H-Index

Concepts

All Affiliations

University of Calgary University of Alberta University of British Columbia Libin Cardiovascular Institute of Alberta University of Ottawa

About

Naushad Hirani is an author at University of Calgary specializing in pulmonary vascular disease, public health, and pulmonary hypertension.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Public Health	6	6	185
2	Medicine	5	5	160
3	Pulmonary Medicine	4	4	114
4	Emergency Medicine	2	2	85
5	Pulmonary Disease	1	1	39

Naushad Hirani

Publications

792

Citations

H-Index

Page 1

	Year	Citations
Combination Therapy with Oral Treprostinil for Pulmonary Arterial Hypertension. A Double-Blind Placebo-controlled Clinical Trial R. James White, Carlos Jerjes‐Sánchez, G. Meyer, American Journal of Respiratory and Critical Care Medicine	2019	142
Impact of management guidelines on the outcome of severe community acquired pneumonia Naushad Hirani, J T Macfarlane Thorax	1997	103
Diagnostic Evaluation and Management of Chronic Thromboembolic Pulmonary Hypertension: A Clinical Practice Guideline Sanjay Mehta, Doug Helmersen, Steeve Provencher, Canadian Respiratory Journal	2010	83
Mortality trends in pulmonary arterial hypertension in Canada: a temporal analysis of survival per ESC/ERS guideline era Jason G.E. Zelt, Jordan Sugarman, Jason Weatherald, European Respiratory Journal	2021	61
Delayed mobilization after microsurgical reconstruction: An independent risk factor for pneumonia Justin Yeung, Robertson Harrop, Olivia McCreary, The Laryngoscope	2013	56
Clinically active serologically quiescent systemic lupus erythematosus. Dafna D. Gladman, Naushad Hirani, Dominique Ibañez, PubMed	2003	51
Seralutinib in adults with pulmonary arterial hypertension (TORREY): a randomised, double-blind, placebo-controlled phase 2 trial Robert P. Frantz, Vallerie V. McLaughlin, Sandeep Sahay, The Lancet Respiratory Medicine Placebo-controlled Phase 2HypertensionPulmonary Arterial HypertensionPulmonary CareCardiovascular Disease	2024	51
A Prospective Evaluation of the Diagnostic Accuracy of the Physical Examination for Pulmonary Hypertension Michael Braganza, Jeffrey Shaw, Kevin Solverson, CHEST Journal HypertensionPulmonary Arterial HypertensionCardiovascular DiseaseDiagnosisProspective Evaluation	2019	46
Reduction of Pulmonary Complications and Hospital Length of Stay with a Clinical Care Pathway after Head and Neck Reconstruction Justin Yeung, Jonathan F. Dautremont, A. Robertson Harrop, Plastic & Reconstructive Surgery	2014	42
Canadian Cardiovascular Society/Canadian Thoracic Society Position Statement on Pulmonary Hypertension Naushad Hirani, Nathan W. Brunner, A. Kapasi, Canadian Journal of Cardiology HypertensionPulmonary CareAdvanced Lung DiseasePulmonary HypertensionPublic Health	2020	39

Page 1